Trials / Sponsors / Jiangsu ShengDiYa Medicine Co., Ltd.
Jiangsu ShengDiYa Medicine Co., Ltd.
Academic / Other · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | Apatinib Combined With Docetaxel Monotherapy as Second-line Therapy of Advanced EGFR WT, Non-squamous NSCLC Nonsquamous Nonsmall Cell Neoplasm of Lung | — | 2016-08-01 |